PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Epilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. aliasadipooya@yahoo.com.\', \'Jefferson Comprehensive Epilepsy Center, Department of Neurology, Thomas Jefferson University, Philadelphia, PA, USA. aliasadipooya@yahoo.com.\', \'Department of Cardiovascular Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.\', \'Health Policy Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.\', \'Department of Clinical Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s10072-020-04549-5
?:doi
?:hasPublicationType
?:journal
  • Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
is ?:pmid of
?:pmid
?:pmid
  • 32594268
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Management of COVID-19 in people with epilepsy: drug considerations.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all